Cargando…
Current Perspectives in Cancer Immunotherapy
Different immunotherapeutic approaches have proved to be of significant clinical value to many patients with different types of advanced cancer. However, we need more precise immunotherapies and predictive biomarkers to increase the successful response rates. The advent of next generation sequencing...
Autores principales: | Christofi, Theodoulakis, Baritaki, Stavroula, Falzone, Luca, Libra, Massimo, Zaravinos, Apostolos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826426/ https://www.ncbi.nlm.nih.gov/pubmed/31575023 http://dx.doi.org/10.3390/cancers11101472 |
Ejemplares similares
-
RNA editing in the forefront of epitranscriptomics and human health
por: Christofi, Theodoulakis, et al.
Publicado: (2019) -
Cross-Talks between RKIP and YY1 through a Multilevel Bioinformatics Pan-Cancer Analysis
por: Baritaki, Stavroula, et al.
Publicado: (2023) -
The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis
por: Lin, Katie, et al.
Publicado: (2022) -
RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity
por: Touboul, Roni, et al.
Publicado: (2021) -
RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact
por: Zaravinos, Apostolos, et al.
Publicado: (2018)